People living with multiple sclerosis have the dice loaded against them when it comes to their decision-making ability as their neurological disease progresses, according to a new study from the University of Alberta's Faculty ...
Jul 8, 2015
0
49
An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study. The drug appears to enhance an innate cellular ...
Mar 13, 2015
0
169
A common gut microbe might curb the risk of developing multiple sclerosis—at least in women—suggests the largest study of its kind published online in the Journal of Neurology Neurosurgery & Psychiatry.
Jan 19, 2015
0
118
(Medical Xpress)—Biogen Idec Inc has released preliminary results of a phase II clinical trial (called RENEW) meant to test the effectiveness of using an anti-LINGO-1 drug called BIIB033, to treat eye damage that occurs ...
Multiple sclerosis (MS), an autoimmune disease of the brain and spinal cord, affects about 2.3 million people worldwide (400,000 in the United States). Affecting more women than men, it can be seen at any age, although it ...
Dec 1, 2014
1
2
(Medical Xpress)—Paula Meltzer was only 38 when out of nowhere everything she looked at was blurry. For the single mother, who had a lucrative career as a gemologist and spent hours examining valuable pieces of jewelry, ...
Sep 4, 2014
2
0
Using a novel screening platform to rapidly evaluate the cellular effects of 1,000 chemical compounds, a team led by UC San Francisco scientists has identified eight drugs that may stimulate nervous system repair in multiple ...
Jul 9, 2014
0
0
A newly identified difference between the brains of women and men with multiple sclerosis (MS) may help explain why so many more women than men get the disease, researchers at Washington University School of Medicine in St. ...
May 8, 2014
0
0
Statins may provide doctors with an unlikely new weapon with which to slow the progression of multiple sclerosis (MS).
Mar 18, 2014
1
1
For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health ...
Jan 20, 2014
0
0
